1. Phoenix Satellite Television (02008.HK): Phoenix New Media's total revenue for the third quarter was RMB 217.6 million, a year-on-year increase of 8.3%.
2. Zhipu (02513.HK): Plans to repurchase H shares worth up to HKD 4 billion, with the total number of shares repurchased not exceeding 1% of the total issued shares as of the announcement date.
3. Alibaba (09988.HK): Plans to spin off Pingtouge Semiconductor and list it independently on the Hong Kong Stock Exchange. The listing application was secretly submitted on September 11.
4. Qingdao Port (06198.HK): Plans to acquire a 70% stake in Qingdao Port Dongjiakou Ore Terminal Co., Ltd., with a transaction amount not exceeding RMB 1.918 billion.
5. Chow Tai Fook Creation (00659.HK): Plans to sell equity in three companies for approximately RMB 1.979 billion. The completion of each sale agreement is not contingent upon the completion of other agreements. After completion, the Group will no longer hold any equity in the target companies.
6. Hesai Technology (02525.HK) announced its unaudited financial results for the third quarter of 2026. Quarterly revenue was RMB 1.068 billion (approximately US$159 million), a year-on-year increase of 34.3%; net profit was RMB 80.8 million, a year-on-year decrease of 68.5%; non-GAAP net profit was RMB 119 million, a year-on-year decrease of 58.6%.
7. Li Auto (02015.HK) officially signed cooperation agreements with partners in Hong Kong, Thailand, Singapore, the Philippines, and Vietnam, aiming to establish a presence in nine markets across the Asia-Pacific region.
8. Simcere Pharmaceutical (02096.HK): Its self-developed CD122 long-acting monoclonal antibody SIM0725 has been approved for clinical trials in China, intended for the treatment of autoimmune diseases.
